Literature DB >> 23455688

Study of metabonomic profiles of human esophageal carcinoma by use of high-resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis.

Yongxia Yang1, Lijing Wang, Shumei Wang, Shengwang Liang, Ali Chen, Huiru Tang, Lei Chen, Feng Deng.   

Abstract

Esophageal carcinoma (EC) is one of the most common malignant tumors. EC survival has remained disappointingly low because of the high malignancy of esophageal cancer and the lack of obvious clinical symptoms at an early stage. Early diagnosis is often difficult because the small tumor nodules are frequently missed. Metabonomics based on high-resolution magic-angle spinning (HRMAS) NMR has been popular for tumor detection because it is highly sensitive, provides rich biochemical information and requires no sample pretreatment. (1)H HRMAS spectra of non-involved adjacent esophageal tissues and of well differentiated and moderately differentiated esophageal carcinoma tumors were recorded and analyzed by use of multivariate and statistical analysis techniques. Moderately differentiated EC tumors were found to have increased total choline, alanine, and glutamate and reduced creatine, myo-inositol, and taurine compared with non-involved adjacent tissues. Moreover, clear differences between the metabonomic profiles of EC tissues enabled tumor differentiation. Furthermore, the integral Gly/MI ratio for samples of different tissue types were statistically significantly different; this was sufficient both for distinguishing non-involved tissues from esophageal carcinoma and for classification of well differentiated and moderately differentiated EC tumors.

Entities:  

Mesh:

Year:  2013        PMID: 23455688     DOI: 10.1007/s00216-013-6774-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  12 in total

1.  High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue.

Authors:  Alice Ly; Achim Buck; Benjamin Balluff; Na Sun; Karin Gorzolka; Annette Feuchtinger; Klaus-Peter Janssen; Peter J K Kuppen; Cornelis J H van de Velde; Gregor Weirich; Franziska Erlmeier; Rupert Langer; Michaela Aubele; Horst Zitzelsberger; Liam McDonnell; Michaela Aichler; Axel Walch
Journal:  Nat Protoc       Date:  2016-07-14       Impact factor: 13.491

2.  HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.

Authors:  Alan S Wang; Alessia Lodi; Lee B Rivera; Jose L Izquierdo-Garcia; Matthew A Firpo; Sean J Mulvihill; Margaret A Tempero; Gabriele Bergers; Sabrina M Ronen
Journal:  NMR Biomed       Date:  2014-09-09       Impact factor: 4.044

3.  Closing the gap between in vivo and in vitro omics: using QA/QC to strengthen ex vivo NMR metabolomics.

Authors:  Amith Sadananda Maroli; Robert Powers
Journal:  NMR Biomed       Date:  2021-08-08       Impact factor: 4.044

Review 4.  Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS).

Authors:  Taylor L Fuss; Leo L Cheng
Journal:  Metabolites       Date:  2016-03-22

5.  NMR Metabolomics in Ionizing Radiation.

Authors:  Jian Zhi Hu; Xiongjie Xiao; Mary Y Hu
Journal:  Clin Oncol (Belmont)       Date:  2016-09-08

6.  Metabolomic Evidence for a Field Effect in Histologically Normal and Metaplastic Tissues in Patients with Esophageal Adenocarcinoma.

Authors:  Michelle A C Reed; Rishi Singhal; Christian Ludwig; John B Carrigan; Douglas G Ward; Phillipe Taniere; Derek Alderson; Ulrich L Günther
Journal:  Neoplasia       Date:  2017-01-31       Impact factor: 5.715

7.  High-resolution 1H NMR spectroscopy of fish muscle, eggs and small whole fish via Hadamard-encoded intermolecular multiple-quantum coherence.

Authors:  Honghao Cai; Yushan Chen; Xiaohong Cui; Shuhui Cai; Zhong Chen
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

8.  Metabolomics for biomarker discovery in gastroenterological cancer.

Authors:  Shin Nishiumi; Makoto Suzuki; Takashi Kobayashi; Atsuki Matsubara; Takeshi Azuma; Masaru Yoshida
Journal:  Metabolites       Date:  2014-07-07

9.  Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups.

Authors:  Sarah Kohe; Marie-Anne Brundler; Helen Jenkinson; Manoj Parulekar; Martin Wilson; Andrew C Peet; Carmel M McConville
Journal:  Br J Cancer       Date:  2015-09-08       Impact factor: 7.640

10.  The metabonomics study of P-selectin glycoprotein ligand-1 (PSGL-1) deficiency inhibiting the progression of atherosclerosis in LDLR-/- mice.

Authors:  Binglin Li; Xin Lu; Jia Wang; Xiaodong He; Quliang Gu; Lijing Wang; Yongxia Yang
Journal:  Int J Biol Sci       Date:  2018-01-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.